TMC278-TIDP6-C222
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TMC278-TIDP6-C222, covering 2021-03-04 to 2021-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Trial With TMC278-TIDP6-C222 for Continued TMC278 Access in Patients Infected With Human Immunodeficiency Virus-1 [Phase 3]